Uniswap topluluğu ekolojik gelişimi teşvik etmek için 165,5 milyon ABD doları ayırdı. DeFi devinin stratejik dönüşüm yolu nerede?

BIOAGE LABS

company

About

BIOAGE targets aging to develop drugs that treat severe diseases

  • 1 - 10

Details

Last Funding Type
Series C
Last Funding Money Raised
$90M
Industries
Biotechnology,Computer
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

BIOAGE discovers and develops drugs to treat aging and associated diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$113M
BIOAGE LABS has raised a total of $113M in funding over 2 rounds. Their latest funding was raised on Dec 3, 2020 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 3, 2020 Series C $90M 1 Detail
Jan 24, 2019 Series B $23M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
BIOAGE LABS is funded by 1 investors. Redpoint are the most recent investors.
Investor Name Lead Investor Funding Round
Redpoint Series C